Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tedja et al: Transcriptional regulation of Candida auris morphogenesis [exp 2]

ABSTRACT: Experiment 2: This experiment concerns the comparison of smooth and wrinkled versus clinical isolates of Candida auris. RNA-seq experiments were performed to correlate differential gene expression in non-fermentable carbon sources to pathogenic traits.

ORGANISM(S): Candidozyma auris

PROVIDER: GSE304033 | GEO | 2026/06/23

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Tedja et al: Transcriptional regulation of Candida auris morphogenesis [exp 3]

Project description:Experiment 3: This experiment concerns the comparison of wild-type and 3 transcription factor mutants and their impacts on gene expression on glucose and lactate media.

2026-06-23 | GSE304034 | GEO

Transcriptional regulation of Candida auris morphogenesis

Project description:Experiment 1: This experiment aimed to transcriptionally characterise two phenotypically different colony morphologies (smooth and wrinkled ) from the C. auris 470140 strain. The smooth colonies are phenotypically round and in yeast yeast from, whereas the wrinkled colonies are made up of elongated pseudo-hyphal cells. The aim was to correlate transcriptomic differences with their respective pathogenic traits

2026-06-23 | GSE303834 | GEO

Tedja et al: Transcriptional regulation of Candida auris morphogenesis [exp 2]

Project description:Tedja et al: Transcriptional regulation of Candida auris morphogenesis [exp 2]

| PRJNA1298801 | ENA

Tedja et al: Transcriptional regulation of Candida auris morphogenesis [exp 3]

Project description:Tedja et al: Transcriptional regulation of Candida auris morphogenesis [exp 3]

| PRJNA1298797 | ENA

A preregistered multi-lab replication of Maier et al. (2014, Exp. 4) testing retroactive avoidance.

Project description: Not available

| S-EPMC7458331 | biostudies-literature

Transcriptional regulation of Candida auris morphogenesis

Project description:Transcriptional regulation of Candida auris morphogenesis

| PRJNA1297744 | ENA

Haploid and Deploid for Candida auris

Project description:The expression difference for haploid and deploid of Candida auris

2020-09-13 | GSE149284 | GEO

Host immune response against the emerging fungal pathogen Candida auris: transcriptional and functional insights

Project description:Candida auris is amongst the most important emerging fungal pathogens, yet mechanistic insights in its immune recognition and control are lacking. Here, we integrate transcriptional and functional immune cell profiling to uncover innate anti-C. auris defense mechanisms. C. auris induces a specific transcriptome in human mononuclear cells, a stronger cytokine response compared to C. albicans, but a lower macrophage lysis capacity. C. auris-induced innate immune activation is mediated through recognition of C-type lectin receptors, mainly elicited by structurally unique C. auris mannoproteins. In in-vivo experimental models of disseminated candidiasis, C. auris was less virulent than C. albicans. Collectively, these results demonstrate that C. auris is a strong inducer of innate host defense and identify possible targets for adjuvant immunotherapy.

2020-07-23 | GSE154911 | GEO

Project description:The goal of this work was to compare strains from the C. auris clades by assessing some virulence factor, such as cell surface hydrophobicity and biofilm formation. Our results indicate key phenotypic differences between strains assigned to different C. auris clades, which were validated by the use of C. auris ALS and IFF mutants (knocked out or reconstituted).

2026-03-19 | PXD074750 | Pride

Overcoming amphotericin B resistance in Candida auris using the antiemetic drug, rolapitant

Project description:The emergence of Candida auris poses a significant health challenge that has led to a new era of multidrug-resistant fungal infections. Invasive infections caused by C. auris are usually associated with remarkable morbidity and mortality. For many years, amphotericin B (AmB) remained the most efficient and the last line of treatment against most hard-to-treat fungal infections. However, strains of C. auris possess extraordinary resistance to most antifungal agents, including AmB. In this study, we screened ~2600 FDA-approved drugs and clinical compounds to identify the antiemetic drug rolapitant as a promising enhancer to AmB against C. auris. Rolapitant exhibited potent synergistic interactions with AmB against all tested (29/29) C. auris isolates. In a time-kill assay, rolapitant restored the fungicidal activity of AmB within 4 h. Additionally, the synergistic relationship between rolapitant and AmB was observed against other medically crucial Candida, Cryptococcus and Aspergillus species with ΣFICI that ranged from 0.16 to 0.5. In a transcriptomic study, ion transporters and ATP generation were identified as primary pathways impacted in C. auris AR0390 cells exposed to rolapitant. An ATP luminescence assay confirmed that rolapitant, at sub-inhibitory concentrations, significantly interfered with ATP production in C. auris. Moreover, rolapitant enhanced the in vivo activity of AmB in a mouse model of disseminated C. auris infection, as the combination reduced the fungal burden in murine kidneys by ~1 log (~90%) colony forming units. Our findings warrant further investigation of using rolapitant to overcome AmB resistance in C. auris and other fungal species.

2024-09-26 | GSE263806 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data